$HEB Recent News Ebola stocks: 2 to sell, and 5 to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$HEB Recent News

Ebola stocks: 2 to sell, and 5 to consider buying 12:09 p.m. Oct. 13, 2014 - The Trading Deck
Wednesday's biggest gaining and declining stocks 6:03 p.m. Dec. 2, 2009 - MarketWatch
Dyax, Santarus, CytRx soar; Hemispherx craters 12:38 p.m. Dec. 2, 2009 - Val Brickates Kennedy
Stocks in focus for Wednesday 7:47 p.m. Dec. 1, 2009 - MarketWatch
Ford tips higher, Santarus surges in late session 7:37 p.m. Dec. 1, 2009 - Laura Mandaro
Hemispherx Biopharma shares sink 44% after hours 6:29 p.m. Dec. 1, 2009 - Laura Mandaro
Oops: I have to eat crow over these stupid picks 9:55 a.m. June 19, 2009 - Chuck Jaffe
Vaccine makers get boost from flu scare 1:20 p.m. May 21, 2009 - Val Brickates Kennedy
Hemispherx leads drug stocks lower 1:29 p.m. May 19, 2009 - Val Brickates Kennedy
Dr. Reddy's, Hemispherx lead drug stocks 1:24 p.m. May 18, 2009 - Val Brickates Kennedy
Pigs will get slaughtered on swine-flu stocks 6:27 p.m. April 30, 2009 - Chuck Jaffe
Shares of antiviral drugmakers rocket on flu news 1:54 p.m. April 27, 2009 - Val Brickates Kennedy
Niche antiviral drugmakers rocket on flu news 10:08 a.m. April 27, 2009 - Val Brickates Kennedy
Hemispherx started at mkt outperform: Boenning & Scattergood 3:47 p.m. Dec. 4, 2006 - Tomi Kilgore
Tuesday's biggest stock gainers and decliners 6:21 p.m. Aug. 29, 2006 - Michael Baron
Short sellers dwindle as multiple forces aim to thwart strategy 11:51 a.m. June 14, 2006 - Alistair Barr
Highlights of rising and falling U.S. stocks 4:58 p.m. May 24, 2006 - MarketWatch
Bird-flu concerns knock airlines, Asian currencies 4:52 p.m. May 24, 2006 - Steve Goldstein
Drug stocks mixed, bird-flu drugmakers rally 4:51 p.m. May 24, 2006 - Val Brickates Kennedy
Hemisherx BioPharma up 10% at $2.95 9:39 a.m. May 24, 2006 - Tomi Kilgore


Hemispherx Announces Strategic Relationship With Squire Patton Boggs, Washington, DC As Governmental Counsel In Fight Against Ebola 11:01 a.m. Today - benzinga.com
Obama appoints Ebola czar 1:35 p.m. Oct. 17, 2014 - Seeking Alpha
Roller coaster ride continues for Ibio 9:09 a.m. Oct. 16, 2014 - Seeking Alpha
Second Texas Ebola case stokes the index 8:57 a.m. Oct. 15, 2014 - Seeking Alpha
Second healthcare worker contracts Ebola in U.S. 5:25 a.m. Oct. 15, 2014 - Seeking Alpha
Ibio jumps on possible ZMapp production ramp 4:18 p.m. Oct. 10, 2014 - Seeking Alpha
Alpha Pro Tech enjoying the Ebola ride 1:52 p.m. Oct. 9, 2014 - Seeking Alpha
Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear 1:38 p.m. Oct. 9, 2014 - Investors Business Daily
Ebola Outbreak Puts the Spotlight on 10 Biotech Companies 12:32 p.m. Oct. 8, 2014 - TheStreet.com
Ebola Patient Eric Duncan Dies; Related Stocks Fall On News 12:04 p.m. Oct. 8, 2014 - benzinga.com
Ebola Sector Shake Out Leaves Chimerix Inc On Top 1:08 p.m. Oct. 6, 2014 - benzinga.com
GeoVax jumps on the Ebola bandwagon 10:35 a.m. Oct. 2, 2014 - Seeking Alpha
Ebola-Related Pharma Stocks Soar On First U.S. Case 1:20 p.m. Oct. 1, 2014 - Investors Business Daily
Why You Should Stay Away From the Ebola Frenzy in Biotech Stocks 10:08 a.m. Oct. 1, 2014 - TheStreet.com
FDA authorizes Tekmira to provide TKM-Ebola 11:20 a.m. Sept. 22, 2014 - Seeking Alpha
Ebola-Stricken Doc Receives Experimental Drug, But Which One? 2:20 p.m. Sept. 11, 2014 - TheStreet.com
Trade Ebola Stocks? Sure, But Don't Bet on Big Business Opportunity 9:36 a.m. Sept. 10, 2014 - TheStreet.com
WHO says Liberia may get overwhelmed by Ebola 7:20 a.m. Sept. 9, 2014 - Seeking Alpha
Hemispherx up in response to DoD Ebola collaboration 11:52 a.m. Sept. 8, 2014 - Seeking Alpha
10-Q: HEMISPHERX BIOPHARMA INC 4:08 p.m. Aug. 8, 2014 - Edgar Online - (EDG = 10Q, 10K)


Hemispherx Announces Strategic Relationship With Squire Patton Boggs, Washington, DC as Governmental Counsel in Fight Against Ebola 12:00 p.m. Today - GlobeNewswire
Hemispherx Biopharma Prevails in Multi-Million Dollar Federal Lawsuit 8:31 a.m. Today - GlobeNewswire
Hemispherx Biopharma Director Dr. William Mitchell to Present Research on Treating Deadly Emerging Viruses During the 4th World Congress on Virology October 8 8:31 a.m. Oct. 7, 2014 - GlobeNewswire
What's Next: Investors Place Ebola Pandemic Stock Bets 7:59 a.m. Oct. 6, 2014 - ACCESSWIRE
Hemispherx Biopharma Expands Research on Potential Ebola Treatments to Five Independent Experts/Institutional Collaborators 8:30 a.m. Sept. 29, 2014 - GlobeNewswire
Market Movers - Biotech Stocks - Hemispherx Biopharma, Aegerion Pharma, Cytori Therapeutics, Alnylam Pharma, and Rexahn Pharma 9:00 a.m. Sept. 25, 2014 - PR Newswire - PRF
Hemispherx Announces Primate Research Showing Alferon(R) LDO Protection From Pulmonary Damage Associated With Infection by Highly Pathogenic Influenza Virus 8:31 a.m. Sept. 22, 2014 - GlobeNewswire
Hemispherx' Drug Ampligen Plus Intranasal Seasonal Influenza Vaccine Induces Cross-Reactive Antibody Formation Against Avian H5N1 and H7N9 Influenza HA in Humans 8:31 a.m. Sept. 15, 2014 - GlobeNewswire
Hemispherx Biopharma and the Swiss Department of Defense, Civil Protection and Sports Expand Their Collaborative Research Agreement to Include the Study of Alferon(R) and Ampligen(R) Against the Ebola Virus 8:31 a.m. Sept. 10, 2014 - GlobeNewswire
Hemispherx Biopharma and United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Agree to Collaborate in Studying Alferon(R) and Ampligen(R) Against the Ebola Virus 8:31 a.m. Sept. 8, 2014 - GlobeNewswire
Hemispherx Biopharma to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th 8:30 a.m. Sept. 3, 2014 - GlobeNewswire
Market Movers - Biotech Stocks -- Progenics Pharma, Rexahn Pharma, ImmunoGen, Hemispherx Biopharma, and Incyte 9:20 a.m. Aug. 21, 2014 - PR Newswire - PRF
Hemispherx Biopharma Announces Financial Results for the Six Months Ended June 30, 2014 8:31 a.m. Aug. 11, 2014 - GlobeNewswire
Hemispherx's Two Drugs, Ampligen(R) and Alferon(R) Ranked Highly in Sensitivity Testing Against MERS/SARS Coronaviruses 8:30 a.m. Aug. 4, 2014 - GlobeNewswire
Hemispherx Achieves High Ranking in Sensitivity Testing Against MERS/SARS Coronaviruses Compared to Other Drugs 8:31 a.m. July 22, 2014 - GlobeNewswire
Hemispherx Biopharma and Bioclones Join Forces in Effort to Eradicate HIV/AIDS Virus Based on Recent Clinical Insights of Wistar Institute, University of Pennsylvania 8:31 a.m. July 8, 2014 - GlobeNewswire
Hemispherx Biopharma to Present During the 2014 BIO International Convention June 26 8:30 a.m. June 25, 2014 - GlobeNewswire
Hemispherx Announces New Publication With Potential Insight Into High Mortality Rate in Middle Eastern Respiratory Syndrome (MERS) 8:31 a.m. June 16, 2014 - GlobeNewswire
Hemispherx Announces That the University of Texas Medical Branch Confirms Activity of Alferon(R) N Against MERS (Middle East Respiratory Syndrome) Virus 1:08 p.m. June 3, 2014 - GlobeNewswire
Hemispherx Receives New U.S. Composition of Matter Patent Covering Ampligen(R) Formulations 9:28 a.m. May 27, 2014 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beverly Hills MD's Dermal Cream Wins Key Beauty Award

Updated Category News Views 1

A Surprise Win in the Beauty World Who doesn't love an underdog story, right? Beverly Hills MD has slid into the limelight with their Dermal Repair Complex snagging the award for 'Beauty Product of the Year.' Talk about sending shockwaves through the beauty industry! Now, these guys might not be a household name yet, but you better believe they've got everyone's attention...

Continue Reading
Truist Revolutionizes Banking with 2 Billion Insights

Updated Category News Views 3

A New Frontier in Banking Truist is out here flipping the script in digital banking, pushing a staggering 2 billion AI-driven insights since 2023. Imagine that—two billion insights 'till now, providing the kind of financial street smarts that help folks feel less like they're lost at sea and more like they're the captain of their own financial ship, all thanks to Truist...

Continue Reading
Photronics Faces Legal Heat: Key Investor Steps Now

Updated Category News Views 0

Eyes on Photronics: A Legal Quake Anytime you hear a stock price nosedive like a kamikaze just blew up its own runway, it ought to set off every investor's alarms. And if you’re tied into Photronics (NASDAQ:PLAB), buddy, it's time to catch up on what's driving this train off the rails. With a class period stretching from December 2025 through May 2026, the dish is a...

Continue Reading
Missouri American Water's $34.5M Neosho Acquisition Outline

Updated Category News Views 0

Missouri American Water Expands in Neosho, Missouri Well, buckle up because Missouri American Water just sealed the deal to take over Neosho's water and wastewater systems. This acquisition cost them a cool $34.5 million and is bringing 5,400 water and another 5,400 wastewater customers into the fold. Plus, they're welcoming onboard 25 local workers who've been in the...

Continue Reading
Stronghold's Unfulfilled Promise May Cost Coachella Millions

Updated Category News Views 0

Coachella's Taxpayer Gamble City of Coachella decided to pull the plug on a deal that could've kept wallets fuller around here. Stronghold Power Systems officials say their shot at leading the municipal utility project got snagged by some bureaucratic red tape or maybe something else. Procurement Process: Two-year-long selection. Investment by Stronghold: $8 million of...

Continue Reading
Mitrade EU Enhances Investor Safety with New Insurance

Updated Category News Views 4

Mitrade's New Insurance: A Safety Net? Mitrade EU is amping up its game with some fresh insurance perks that catch the eye. They're slapping on some extra insolvency protection for clients trading under their CySEC license. Now that sounds like a financial shield anyone would want. Basically, they're adding another layer to the basic regulatory protections, and without...

Continue Reading
Finzly Launches AI Security Layer Amid Rising Threats

Updated Category News Views 5

Bank Security in the Age of AI You'd think banks, of all places, were impenetrable fortresses. But these days, they're more like digital targets. With AI-driven attacks becoming as common as morning coffee, Finzly's introducing Assure, an AI-powered security and assurance layer. It's about as timely as ever, given the 89% spike in AI-enabled attacks seen last year. When...

Continue Reading
Connected Retail Security: Rising Risks and Fragmented Roles

Updated Category News Views 0

Cyber Threats in the Connected Retail Landscape The retail world isn't what it used to be. Walk into a store today, and you're greeted not just by products but a web of interconnected systems screaming for attention. Sure, you've got your old-school POS systems humming along, but they're just one brittle cog in a rattling machine of IoT devices, cloud platforms, and...

Continue Reading
Lundbeck's Bexicaserin Insights Rock Epilepsy Congress

Updated Category News Views 5

Breaking Down Bexicaserin's Dual Action Seems like Lundbeck's playing the long game with bexicaserin, and boy, are they shaking things up at the European Epilepsy Congress. This isn't your usual sit-back-and-watch situation. They're putting bexicaserin's dual mode of action under a magnifying glass, aiming to hit both sides of the brain's seesaw by increasing inhibitory...

Continue Reading
Little Sunshine's Opens New School in Peoria, AZ

Updated Category News Views 2

Betting On Early Childhood Education Little Sunshine's Playhouse breaks ground on a fresh hub of learning in Peoria, Arizona, and this is no small playdate. It's the dawn of another preschool institution aiming to mold the early years of countless kiddos. The gears turning behind this development are impressive by themselves, but it's what it means for Peoria's families...

Continue Reading

Top 5 Most Recently Viewed Articles

Mid-Cap Surge Signals Positive Market Trends for 2026

Updated Category News Views 230

Key Market Highlights The global equities market is experiencing a strong surge, showcasing a shift in leadership that extends beyond the traditional mega-cap technology industry. This rotation has been particularly evident with mid-cap stocks reaching record highs, a clear indication of improved market breadth and sector balance. Mid-caps have emerged as a favored choice...

Continue Reading
Ruder Finn Achieves Top Ranking Among PR Firms Once Again

Updated Category News Views 444

Ruder Finn Celebrates #2 Ranking on Observer's PR Power List In an exciting announcement, Ruder Finn, one of the leading independent communications and marketing agencies, has achieved the impressive feat of being ranked #2 on Observer's prestigious PR Power List. This recognition underscores the agency's success in the field and highlights its culturally relevant and...

Continue Reading
Visionary Copper and Gold Mines Secures Funding for Growth

Updated Category News Views 153

Exciting Developments at Visionary Copper and Gold Mines Inc. VANCOUVER, British Columbia — Visionary Copper and Gold Mines Inc. (the "Company" or "Visionary") (TSXV: VCG) (OTCQX: VCGMF) is thrilled to share news about its latest initiative, a non-brokered private placement expected to raise up to $3.0 million. The funds generated will significantly contribute to the...

Continue Reading
W. P. Carey Exceeds Expectations with $1.6 Billion in 2024

Updated Category News Views 240

W. P. Carey Reports Record Investment Volume for 2024 W. P. Carey Inc. (NYSE: WPC), a prominent real estate investment trust (REIT) involved in net leasing, has recently unveiled impressive investment achievements for 2024. The company recorded a total investment volume of about $1.6 billion, driven by a robust focus on high-quality assets. This significant figure...

Continue Reading
PleoPharma Makes Strides in Cannabis Withdrawal Treatment

Updated Category News Views 91

Positive Phase 2b Results for PleoPharma's Lead Drug PleoPharma, Inc., a clinical-stage company dedicated to addressing cannabis-related health challenges, has made impressive strides in its research efforts. The company recently shared the outcomes of its Phase 2b clinical trial for its primary drug candidate, PP-01, which is specifically designed to help alleviate...

Continue Reading